1. 1. World Health Organization. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. 2018.
2. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study;Tozun;Clin Microbiol Infect,2015
3. 3. Tosun S, Balık İ, Tabak F, et al. Evaluation of Risk Factors Associated with HBsAg and Anti-HCV Seropositivity: Results of a Nationwide Population-based Epidemiological Survey Study in Turkey. Mediterr J Infect Microb Antimicrob 2018;7:34.
4. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing;Omata;Hepatol Int,2016
5. 5. Yenilmez E, Çetinkaya R, Sarıkaya B, Akkaya Işık S, Baylan O, Görenek L. Diagnostic Reliability of Architect Anti HCV Test in Low-Risk Population. Bozok Tıp Derg 2019;9:127-31.